2016
DOI: 10.1155/2016/9231946
|View full text |Cite
|
Sign up to set email alerts
|

Quality of Sulfadoxine-Pyrimethamine Given as Antimalarial Prophylaxis in Pregnant Women in Selected Health Facilities in Central Region of Ghana

Abstract: The use of sulfadoxine-pyrimethamine (SP) as an intermittent preventive treatment (IPT) against malaria during pregnancy has become a policy in most sub-Sahara African countries and crucially depends on the efficacy of SP. This study sets out to evaluate the effectiveness of the SP given to the pregnant women in some selected health facilities in the Central Region of Ghana to prevent maternal malaria in pregnant women. A total of 543 pregnant women recruited from 7 selected health centres in Central Region of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
14
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 20 publications
0
14
0
Order By: Relevance
“…Another possible reason is the availability of poor quality sulfadoxine–pyrimethamine; some SP drugs on the Ghanaian market have been found to be of low quality. A recent study found 2 out of 3 SP drugs given at hospitals in the Central region of Ghana to pregnant women failed the drug dissolution test, even though they contained the active ingredient [ 43 ]. This means that the amount of the drug that was able to dissolve within a particular period and be available for absorption in the body was very low; the drugs were therefore not effective [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Another possible reason is the availability of poor quality sulfadoxine–pyrimethamine; some SP drugs on the Ghanaian market have been found to be of low quality. A recent study found 2 out of 3 SP drugs given at hospitals in the Central region of Ghana to pregnant women failed the drug dissolution test, even though they contained the active ingredient [ 43 ]. This means that the amount of the drug that was able to dissolve within a particular period and be available for absorption in the body was very low; the drugs were therefore not effective [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…In Ghana, Yeboah et al found a malaria prevalence of 11.2% in women who received IPT with SP and have thus questioned the efficacy of the treatment. 31 Single marital status was associated with malaria infection in these patients. Singles areusually young and more prone to malaria infection compared with older women since they are still in the process of acquiring immunity against malaria.…”
Section: Discussionmentioning
confidence: 86%
“…As a result, the first line of drug for the treatment of P. falciparum malaria cases was changed from sulfadoxinepyrimethamine to artemether lumefantrine after the mentioned year as above [36]. For instance, one study conducted in Ghana showed that sulfadoxine-pyrimethamine was substandard in treating malaria cases [74]. In areas where SP implementation, growing resistance to sulfadoxine-pyrimethamine is an emerging challenge [75].…”
Section: Treatment Strategies Of Malariamentioning
confidence: 99%
“…In areas where SP implementation, growing resistance to sulfadoxine-pyrimethamine is an emerging challenge [75]. In contrast, using sulfadoxine-pyrimethamine (SP) as an intermittent preventive therapy against the disease during pregnancy is becoming a policy in most sub-Sahara African regions before years [74].…”
Section: Treatment Strategies Of Malariamentioning
confidence: 99%